Feb 26, 2026 07:42PM
Feb 11, 2026 06:27PM
Jan 28, 2026 06:54PM
Jan 26, 2026 06:45PM
Jan 18, 2026 07:01PM
Jan 8, 2026 06:46PM
Jan 1, 2026 06:02PM Mesoblast names Facchina as new chair, Bell to stay as director
Jan 1, 2026 06:02PM
Dec 29, 2025 06:57PM
Dec 21, 2025 04:00AM
Dec 11, 2025 06:22PM
Dec 3, 2025 06:10PM
Nov 24, 2025 06:39PM
Nov 20, 2025 06:32PM Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
Nov 4, 2025 06:40PM
Oct 19, 2025 07:48PM
Oct 6, 2025 07:24PM
Oct 2, 2025 09:04PM
Sep 26, 2025 01:49AM
Sep 14, 2025 09:18PM
Sep 3, 2025 09:47PM Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
Aug 28, 2025 08:24PM
Jul 17, 2025 08:38PM
Jun 30, 2025 08:36PM
Jun 11, 2025 09:24PM
May 14, 2025 11:36PM
May 14, 2025 10:57PM
Apr 29, 2025 08:53PM Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025
Apr 28, 2025 07:44PM
Apr 3, 2025 06:58PM
Apr 2, 2025 07:15PM
Mar 30, 2025 07:39PM
Mar 13, 2025 07:42PM
Mar 6, 2025 06:54PM
Feb 26, 2025 05:30PM Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
Feb 25, 2025 06:13PM
Feb 23, 2025 06:33PM
Feb 13, 2025 06:37PM
Jan 30, 2025 07:11PM
Jan 30, 2025 06:20PM
Dec 23, 2024 03:02AM
Dec 19, 2024 07:59AM Mesoblast Limited (MESO) PT Raised to $15 at Piper Sandler as FDA Approves Ryoncil
Dec 18, 2024 07:08PM
Dec 18, 2024 05:04PM
Dec 18, 2024 07:30AM
Dec 4, 2024 06:32PM
Dec 2, 2024 06:20PM
Oct 30, 2024 07:11PM
Sep 29, 2024 08:55PM Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch
Aug 29, 2024 07:50AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All